MDT

89.34

+0.27%↑

VEEV

281.18

-0.98%↓

A

124.13

+2.21%↑

WBA

11.54

-0.09%↓

HQY

97.12

-2.5%↓

MDT

89.34

+0.27%↑

VEEV

281.18

-0.98%↓

A

124.13

+2.21%↑

WBA

11.54

-0.09%↓

HQY

97.12

-2.5%↓

MDT

89.34

+0.27%↑

VEEV

281.18

-0.98%↓

A

124.13

+2.21%↑

WBA

11.54

-0.09%↓

HQY

97.12

-2.5%↓

MDT

89.34

+0.27%↑

VEEV

281.18

-0.98%↓

A

124.13

+2.21%↑

WBA

11.54

-0.09%↓

HQY

97.12

-2.5%↓

MDT

89.34

+0.27%↑

VEEV

281.18

-0.98%↓

A

124.13

+2.21%↑

WBA

11.54

-0.09%↓

HQY

97.12

-2.5%↓

Search

Altimmune Inc

Geschlossen

4.39 -6.99

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

3.96

Max

4.72

Schlüsselkennzahlen

By Trading Economics

Einkommen

3.6M

-20M

Verkäufe

5K

Gewinnspanne

-391,500

Angestellte

59

EBITDA

2.9M

-20M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+274.47% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

7. Aug. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-104M

359M

Vorheriger Eröffnungskurs

11.38

Vorheriger Schlusskurs

4.39

Technischer Score

By Trading Central

Vertrauen

Bullish Evidence

Altimmune Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

10. Juli 2025, 21:42 UTC

Akquisitionen, Fusionen, Übernahmen

Justice Department Won't Seek Injunction for T-Mobile Acquisition of U.S. Cellular

10. Juli 2025, 17:06 UTC

Akquisitionen, Fusionen, Übernahmen

Portugal Begins Process to Sell Stake in National Carrier -- Update

10. Juli 2025, 17:00 UTC

Wichtige Markttreiber

K Wave Media Shares Drop After Convertible Note Agreement With Anson Funds

10. Juli 2025, 16:31 UTC

Akquisitionen, Fusionen, Übernahmen

Blackstone Makes $664 Million Counteroffer for Warehouse REIT Amid Bidding War -- 2nd Update

10. Juli 2025, 23:47 UTC

Market Talk

Gold Edges Higher Amid Lingering Global Trade Tensions -- Market Talk

10. Juli 2025, 23:40 UTC

Market Talk

Nikkei May Trade Rangebound Amid U.S. Tariff Uncertainty -- Market Talk

10. Juli 2025, 22:36 UTC

Market Talk

Tourism Holdings' Profit Warning Less Concerning Than Others -- Market Talk

10. Juli 2025, 22:23 UTC

Market Talk

New Law Creates Winners and Losers Among Renewable-Energy Projects -- Market Talk

10. Juli 2025, 20:50 UTC

Market Talk
Ergebnisse

Auto & Transport Roundup: Market Talk

10. Juli 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

10. Juli 2025, 20:00 UTC

Akquisitionen, Fusionen, Übernahmen

Toyota Tsusho America Completes Acquisition of Radius Recycling

10. Juli 2025, 19:56 UTC

Market Talk

Gold Rises on Inflation Concerns -- Market Talk

10. Juli 2025, 19:33 UTC

Market Talk

Oil Snaps Winning Streak As Oversupply Concerns Return -- Market Talk

10. Juli 2025, 19:21 UTC

Market Talk

U.S. Natural Gas Rebound on Benign Storage Build -- Market Talk

10. Juli 2025, 18:46 UTC

Market Talk

Mexican Industrial Production Seen as Mixed in May -- Market Talk

10. Juli 2025, 18:15 UTC

Market Talk

Brazil's Bullish Outlook Expected to Survive Trump Tariffs -- Market Talk

10. Juli 2025, 18:03 UTC

Market Talk
Ergebnisse

Travel Agency Investors Cautiously Optimistic After Delta Report -- Market Talk

10. Juli 2025, 17:57 UTC

Market Talk

US Labor Shortage Could Weigh on Business, Economic Growth -- Market Talk

10. Juli 2025, 17:34 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Conagra Falls While Simply Good Foods Adapts. What's Eating Food Companies. -- Barrons.com

10. Juli 2025, 17:34 UTC

Market Talk

Canada Vows Fight Over Trump's Copper Tariffs -- Market Talk

10. Juli 2025, 17:20 UTC

Market Talk

Copper Climbs as Futures Wrangle With Trump Tariff -- Market Talk

10. Juli 2025, 17:20 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

10. Juli 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

10. Juli 2025, 16:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

10. Juli 2025, 16:20 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

10. Juli 2025, 16:02 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

10. Juli 2025, 16:02 UTC

Market Talk

Global Equities Roundup: Market Talk

10. Juli 2025, 16:02 UTC

Market Talk

Embraer Expected to Bear Brunt of U.S. Tariffs on Brazil -- Market Talk

10. Juli 2025, 16:01 UTC

Akquisitionen, Fusionen, Übernahmen

Investor AB: Advanced Instruments' Acquisition of Nova Biomedical Completed

10. Juli 2025, 15:41 UTC

Market Talk

U.S. Natural Gas Storage Surplus Holds Steady -- Market Talk

Peer-Vergleich

Kursveränderung

Altimmune Inc Prognose

Kursziel

By TipRanks

274.47% Vorteil

12-Monats-Prognose

Durchschnitt 17.75 USD  274.47%

Hoch 28 USD

Tief 1 USD

Basierend auf 11 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Altimmune Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

11 ratings

8

Buy

2

Halten

1

Sell

Technischer Score

By Trading Central

5.365 / 6.0486Unterstützung & Widerstand

Kurzfristig

Bullish Evidence

Mittelfristig

Weak Bullish Evidence

Langfristig

Bearish Evidence

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Altimmune Inc

Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, a GLP-1/glucagon dual receptor agonist that is in Phase 2 trial for the treatment of obesity and metabolic dysfunction-associated steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.